In 2002, the people who later founded PointCare were approached by friends involved in the worldwide push to provide AIDS therapy to patients in resource-poor regions. They knew that Peter Hansen, the key innovator at PointCare, had already invented the first automated CD4 test. This approach resulted in our quest to “come up with an affordable version”.
During months of travel in Africa, we discovered it wasn’t enough just to lower the cost of the diagnostic solutions used in industrialised nations. We saw many donated flow cytometers under dust covers. Why? We realised that — to be successful in resource-limited environments — diagnostic solutions must be easy to use (any caregiver should be able to use them) and must operate from any power source. Also we found that reagents must be heat-stable both in transport and storage.
Remembering the glimmer of hope in caregivers’ eyes when we promised these criteria could be met, we became more resolved. We set out to invent what is now the only product that fulfils these needs in resource-poor settings.